Chemed Co. (NYSE:CHE) Stock Holdings Trimmed by Squarepoint Ops LLC

Squarepoint Ops LLC trimmed its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 13.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,512 shares of the company's stock after selling 5,506 shares during the quarter. Squarepoint Ops LLC owned about 0.24% of Chemed worth $19,344,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Twinbeech Capital LP acquired a new stake in shares of Chemed in the 4th quarter valued at approximately $2,506,000. Tidal Investments LLC increased its stake in Chemed by 1,315.1% in the 4th quarter. Tidal Investments LLC now owns 24,085 shares of the company's stock valued at $12,760,000 after purchasing an additional 22,383 shares in the last quarter. Second Line Capital LLC increased its stake in Chemed by 16.4% in the 4th quarter. Second Line Capital LLC now owns 5,353 shares of the company's stock valued at $2,836,000 after purchasing an additional 756 shares in the last quarter. Snowden Capital Advisors LLC increased its stake in Chemed by 17.4% in the 4th quarter. Snowden Capital Advisors LLC now owns 1,105 shares of the company's stock valued at $585,000 after purchasing an additional 164 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in Chemed in the 4th quarter valued at approximately $54,587,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the transaction, the chief executive officer now owns 101,197 shares in the company, valued at approximately $58,335,010.65. This trade represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last 90 days, insiders have sold 7,500 shares of company stock worth $4,401,120. 3.29% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Royal Bank of Canada raised their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Chemed Stock Up 0.7%

Shares of NYSE:CHE traded up $4.24 during midday trading on Tuesday, reaching $573.81. The company's stock had a trading volume of 21,328 shares, compared to its average volume of 118,139. The firm has a market cap of $8.39 billion, a price-to-earnings ratio of 29.03, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.60. The business has a 50 day moving average price of $582.91 and a 200 day moving average price of $565.59.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.20 earnings per share. Sell-side analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's payout ratio is currently 9.74%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.